Insight Molecular Diagnostics (IMDX) Share-based Compensation Growth (5y) (2020 - 2026)
Insight Molecular Diagnostics (IMDX) Share-based Compensation Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 29,149.49 Bn | 29,149.03 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 174.37 Bn | 171.12 Bn | 7.74 Bn |
| 3 | Danaher | 127.33 Bn | 121.64 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 44.68 Bn | 44.48 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 36.54 Bn | 34.74 Bn | 990.00 Mn |
| 6 | Iqvia Holdings | 30.51 Bn | 28.53 Bn | 1.36 Bn |
| 7 | Natera | 30.00 Bn | 28.90 Bn | 696.04 Mn |
| 8 | Illumina | 24.61 Bn | 23.45 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 22.91 Bn | 22.85 Bn | 555.82 Mn |
| 10 | Insight Molecular Diagnostics | 4.29 Mn | -24.64 Mn | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.77% |
| Dec 31, 2025 | -6.05% |
| Sep 30, 2025 | -21.82% |
| Jun 30, 2025 | -18.02% |
| Mar 31, 2025 | -12.78% |
| Sep 30, 2024 | -11.33% |
| Jun 30, 2024 | -11.25% |
| Mar 31, 2024 | -9.43% |
| Dec 31, 2023 | 3.89% |
| Sep 30, 2023 | 12.06% |
| Jun 30, 2023 | 16.48% |
| Mar 31, 2023 | 19.17% |
| Dec 31, 2022 | 40.88% |
| Sep 30, 2022 | 47.09% |
| Jun 30, 2022 | 45.19% |
| Mar 31, 2022 | 41.85% |
| Dec 31, 2021 | 41.27% |
| Jun 30, 2021 | 62.34% |
| Mar 31, 2021 | 59.49% |
| Dec 31, 2020 | 0.02% |